Trial intelligence / Profile preview

Magnesium sulfate and reducing sedative requirement in mechanically ventilated patients

IRCT20100228003449N33Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in pain, agitation, delirium and 1 more, sponsored by Tehran University of Medical Sciences. Started Dec 2024; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

painagitationdelirium

Beyond the preview

Go deeper on IRCT20100228003449N33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100228003449N33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call